Vietnam Enforces New Disclosure Rules for Biocides in Packaging

On May 27, 2026, Vietnam’s Ministry of Health and Ministry of Industry and Trade jointly implemented Circular No. 18/2026/TT-BYT, mandating disclosure and toxicological assessment for specific insecticidal and fungicidal active ingredients—including triclosan and isothiazolinones—in packaging materials used for imported kitchenware, maternity & infant care products, and gift/lifestyle sets. This development directly affects manufacturers, importers, and e-commerce fulfillment providers relying on biodegradable or functional packaging—making it a critical regulatory signal for global suppliers serving the Vietnamese market.

Event Overview

Vietnam’s Circular No. 18/2026/TT-BYT took effect on May 27, 2026. It requires that all imported kitchen utensils, maternity & infant care products (including pet supplies), and gift & lifestyle product sets must disclose, on labeling, any presence of specified pesticidal or antimicrobial active substances—such as triclosan and isothiazolinone derivatives—in their packaging materials. Affected products must also submit supporting toxicological evaluation reports. Non-compliant shipments face port rejection or destruction. The regulation explicitly references implications for biodegradable packaging materials and e-commerce fulfillment packaging (e-commerce fulfillment packs).

Industries Impacted by Segment

Direct Importers & Trading Companies: These entities bear primary compliance responsibility at customs clearance. They are affected because label disclosures and submission of toxicological dossiers must be completed prior to entry—and documentation must align precisely with physical packaging composition. Impact manifests as increased pre-shipment verification workload, risk of shipment delays, and potential financial loss from rejected consignments.

Raw Material Suppliers & Compounders: Suppliers of masterbatches, antimicrobial additives, or coated films used in packaging are impacted indirectly but significantly. Buyers may now require updated safety data sheets (SDS), full substance declarations, and evidence of non-use of listed actives—especially for formulations marketed as ‘antibacterial’ or ‘odor-control’. This shifts technical documentation expectations upstream.

Contract Packaging & Finished Goods Manufacturers: Firms producing printed pouches, molded trays, or laminated boxes for targeted product categories must verify formulation compliance across all layers—including adhesives, inks, and surface treatments. Impact includes revised internal quality checklists, supplier qualification updates, and potential reformulation timelines if legacy antimicrobial additives are present.

E-commerce Fulfillment Service Providers: As the regulation names ‘e-commerce fulfillment packs’ explicitly, third-party logistics (3PL) and fulfillment centers handling final packaging for cross-border sellers must ensure that outbound kits—including branded mailer boxes, padded envelopes, or insert cards—meet disclosure requirements when those items fall under regulated categories. This introduces new compliance checkpoints beyond standard shipping labeling.

Key Focus Areas and Immediate Actions for Stakeholders

Monitor official guidance and interpretation notes

The circular does not yet specify which exact isothiazolinone variants are covered (e.g., MIT, CMIT, OIT), nor does it define thresholds for ‘presence’ triggering disclosure. Stakeholders should track follow-up notices from Vietnam’s Drug Administration (under MOH) and General Department of Vietnam Customs for clarification—particularly on analytical testing expectations and acceptable report formats.

Map exposure across high-risk SKUs and packaging tiers

Companies should prioritize review of packaging used for: (1) baby bottles, feeding accessories, and diaper bags; (2) reusable food storage containers and cutting boards; (3) premium gift sets with printed rigid boxes or antimicrobial-coated tissue wraps. Attention should extend beyond primary packaging to secondary elements like hang tags, stickers, or cushioning inserts that may contain undisclosed biocides.

Distinguish between regulatory signal and operational enforcement

While the rule is legally effective as of May 27, 2026, initial enforcement may focus on high-volume or high-risk entries. Analysis shows customs authorities often phase in document checks over 3–6 months. However, label disclosure is enforceable immediately—meaning non-compliant labels (even with compliant content) may trigger rejection regardless of dossier status.

Initiate cross-functional alignment now—not after first refusal

Supply chain, regulatory affairs, procurement, and marketing teams must jointly audit current packaging specifications, update vendor questionnaires, and revise artwork approval workflows. For brands using co-packers, contractual clauses on regulatory compliance liability and documentation handover should be reviewed and, where needed, amended ahead of Q3 2026 shipments.

Editorial Perspective / Industry Observation

Observably, this circular functions less as an outright ban and more as a transparency-driven risk-mitigation framework—aligning with ASEAN’s broader trend toward harmonized chemical management in consumer-facing supply chains. Analysis shows it mirrors aspects of EU Biocidal Products Regulation (BPR) Article 58 labelling obligations, though without equivalent product authorization. From an industry perspective, it signals Vietnam’s increasing prioritization of post-market traceability for bioactive substances—even in non-intended-contact applications like outer packaging. Current enforcement patterns suggest it is best understood not as a one-time compliance hurdle, but as the opening phase of sustained scrutiny on functional additives in everyday consumer packaging.

Conclusion
This regulation marks a formal escalation in Vietnam’s oversight of biocidal substances within consumer product packaging—not through prohibition alone, but via mandatory disclosure and evidence-based justification. Its significance lies not only in immediate customs requirements, but in its role as a precedent for how functional additives will be governed across ASEAN markets moving forward. Currently, it is more appropriately understood as a structural shift in compliance expectations—requiring proactive ingredient mapping and documentation readiness—rather than a short-term procedural adjustment.

Source Attribution
Main source: Vietnam Ministry of Health & Ministry of Industry and Trade, Circular No. 18/2026/TT-BYT, effective May 27, 2026.
Note: Thresholds for reporting, list of covered isothiazolinone derivatives, and accepted toxicological report templates remain pending official clarification and are under ongoing observation.